Debut Plus

35.38

+3.92 +12.46%

10 Sept 2026

NSE Listed · Pharmaceuticals

Biofil Chemicals & Pharmaceuticals Ltd. (BIOFILCHEM)

Volume: 2,38,187Avg Vol 1W: 54,096Avg Vol 1M: 75,34652W Range:25.646.34
Market Cap₹58 Cr
Current Price₹35.38
Previous Close₹31.46
High / Low (52w)₹46.34 / ₹25.6
Volume2,38,187
Avg Vol (1W)54,096
Avg Vol (1M)75,346
Stock P/E117.93
Book Value₹13.25
Dividend Yield0%
ROE12.92%
ROA112.02%
Revenue (TTM)
Revenue Growth
Profit Margin139.86%
Total Debt
Shares Outstanding2 Cr
Face Value₹10
EPS (TTM)₹0.3
P/B2.67
Debt / Equity0.09
50 DMA₹32.64
200 DMA₹33.31
Day change+12.46%
Price Chart
35.38 19.72% · 1Y
50268.9L
2025-09-10
2026-09-10

20-day avg volume: 82K shares

Pros
  • Company is almost debt-free.
  • Net profit is growing year over year.
Cons
  • Stock trades at a high P/E of 118.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹2 Cr₹14 Cr₹8 Cr₹6 Cr₹14 Cr₹1 Cr₹8 Cr₹12 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹3 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹2 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EPS
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹23 Cr₹30 Cr₹37 Cr₹23 Cr₹30 Cr₹41 Cr₹34 Cr₹31 Cr
EBITDA₹1 Cr₹2 Cr₹2 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹3 Cr
Net Profit₹0 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr₹3 Cr
EPS0.30.740.770.440.340.440.341.71
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹24 Cr₹42 Cr₹33 Cr₹19 Cr₹31 Cr₹47 Cr₹51 Cr₹43 Cr
Total Liabilities₹11 Cr₹27 Cr₹17 Cr₹2 Cr₹14 Cr₹29 Cr₹32 Cr₹21 Cr
Equity₹14 Cr₹15 Cr₹16 Cr₹17 Cr₹17 Cr₹18 Cr₹19 Cr₹22 Cr
Total Debt
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹2 Cr₹0 Cr₹0 Cr₹3 Cr₹-2 Cr₹0 Cr
Investing₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr
Financing₹-1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹3 Cr
Free Cash Flow₹2 Cr₹0 Cr₹0 Cr₹3 Cr₹-2 Cr₹0 Cr
Shareholding
Promoter 46.79% Institutions 0.08% Public 53.13%
Efficiency & Working Capital
ROCE14.1%
Interest Coverage65
Dividend Payout
Debtor Days355 d
Inventory Days51 d
Payable Days219 d
Cash Conversion Cycle187 d
Working Capital Days406 d
Shareholding Details

As of 2026-06-30

Promoter46.8%
FII0%
DII0.1%
Institutions0.1%
Public53.1%
Promoter Pledge0%
No. of Shareholders24,999
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters46.8%46.8%46.8%46.8%46.8%46.8%46.8%46.8%46.8%46.8%46.8%46.8%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%0.1%
Public53.1%53.1%53.1%53.1%53.1%53.1%53.1%53.1%53.1%53.1%53.1%53.1%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders26,12325,86426,58125,48026,42226,11425,91425,68525,19624,82525,35624,999
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603
Major Shareholders (>1%)
NameCategoryStakeShares
Scope Finance Company Private LimitedShareholding of Promoter and Promoter Group13.9%22,62,500
Mid (india) Pharmaceuticals Pvt LtdShareholding of Promoter and Promoter Group7.2%11,75,250
Starline Equifin Private LimitedPublic Shareholding7.1%11,49,872
Cyano Finance And Sales Pvt. Ltd.Shareholding of Promoter and Promoter Group5.4%8,76,450
Meena ShahShareholding of Promoter and Promoter Group4.1%6,60,312
Niyati ShahShareholding of Promoter and Promoter Group4.1%6,59,312
Ketan ShahShareholding of Promoter and Promoter Group3%4,93,062
Sandeep ShahShareholding of Promoter and Promoter Group2.6%4,23,812
Romil ShahShareholding of Promoter and Promoter Group2.4%3,82,550
Ksl And Industries LimitedPublic Shareholding1.9%3,08,065
Kishor Himmatsinh JhalaPublic Shareholding1.2%1,97,836
Smitesh Sanalal ShahShareholding of Promoter and Promoter Group1.2%1,86,662
Gom Industries LtdPublic Shareholding1.1%1,80,800
Trupti ShahShareholding of Promoter and Promoter Group0.6%1,01,750
Ritu ShahShareholding of Promoter and Promoter Group0.6%90,100
Manali SimonShareholding of Promoter and Promoter Group0.5%87,200
Meet ShahShareholding of Promoter and Promoter Group0.5%87,200
Rohan ShahShareholding of Promoter and Promoter Group0.4%65,500
Kiran ShahShareholding of Promoter and Promoter Group0.4%63,100
Board of Directors
NameDesignationYear
Ketan ShahChairman / Executive Director / M D / Promoter2025
Meet ShahNon-Exec & Non-Independent Dir2025
Ashok Kumar RamawatIndependent Non Exe. Director2025
Satish BeoharIndependent Non Exe. Director2025
Gayatri PadiyarIndependent Non Exe. Director2025
Smitesh ShahNon-Exec & Non-Independent Dir2025
Apoorv JainCompany Sec. & Compli. Officer2025
Segments — Product
SegmentRevenueShare
Pharma₹19 Cr66.8%
Chemicals₹9 Cr33.2%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10201616
Corporate Actions
TypeDateValueRemark
forthcoming2026-08-11Board Meetings
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2026000089
2026000055
2026000012
Insider / Designated-Person Trades

2 recent disclosure(s)

NIYATI SHAHDisposal · 32,657
MEENA SHAHAcquisition · 32,657
Substantial Acquisitions (SAST)

3 disclosure(s)

Off Market Gift11/03/2024 · 87,200
Off Market Gift11/03/2024 · 87,200
Off Market Gift11/03/2024 · 87,200
Company Information
Incorporated1985
ChairmanKetan Shah
AuditorMaheshwari & Gupta
🌐 www.biofilgroup.net

📍 11/12 Sector E Sanwer Road, Sanwer Road Industrial Area, Indore, Madhya Pradesh, 452015

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search